Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Shuntai Zhou
Affiliation
University of North Carolina at Chapel Hill
ORCID
Career Start Year
2010
Papers
41
H Index
18
Expertise
CM4AI Collaborator
Wade Schulz (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36791724
Accelerated SARS-CoV-2 intrahost evolution leading to distinct genotypes during chronic infection.
Cell Rep Med
2023
37662274
<i>N</i><sup>4</sup> -Hydroxycytidine/Molnupiravir Inhibits RNA-Virus Induced Encephalitis by Producing Mutated Viruses with Reduced Fitness.
bioRxiv
2023
37283544
Use of Next-Generation Sequencing in a State-Wide Strategy of HIV-1 Surveillance: Impact of the SARS-COV-2 Pandemic on HIV-1 Diagnosis and Transmission.
J Infect Dis
2023
36920025
Selection of HIV-1 for resistance to fifth-generation protease inhibitors reveals two independent pathways to high-level resistance.
Elife
2023
36717718
Rebound HIV-1 in cerebrospinal fluid after antiviral therapy interruption is mainly clonally amplified R5 T cell-tropic virus.
Nat Microbiol
2023
34628443
HIV-1 drug resistance and genetic diversity in a cohort of people with HIV-1 in Nigeria.
AIDS
2022
36043120
COVID-19 Outcomes in Stage IV Cancer Patients Receiving Immune Checkpoint Inhibitors.
SN Compr Clin Med
2022
36066505
A Single Center Retrospective Study of the Impact of COVID-19 Infection on Immune-related Adverse Events in Cancer Patients Receiving Immune Checkpoint Inhibitors.
J Immunother
2022
36326446
Unique Molecular Identifiers and Multiplexing Amplicons Maximize the Utility of Deep Sequencing To Critically Assess Population Diversity in RNA Viruses.
ACS Infect Dis
2022
35975998
Characterization of Macrophage-Tropic HIV-1 Infection of Central Nervous System Cells and the Influence of Inflammation.
J Virol
2022
32663847
Near Real-Time Identification of Recent Human Immunodeficiency Virus Transmissions, Transmitted Drug Resistance Mutations, and Transmission Networks by Multiplexed Primer ID-Next-Generation Sequencing in North Carolina.
J Infect Dis
2021
33796612
Primer ID Next-Generation Sequencing for the Analysis of a Broad Spectrum Antiviral Induced Transition Mutations and Errors Rates in a Coronavirus Genome.
Bio Protoc
2021
33961695
β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells.
J Infect Dis
2021
34255064
Reply to Troth et al.
J Infect Dis
2021
32253226
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice.
Sci Transl Med
2020
31914800
HIV-1 Central Nervous System Compartmentalization and Cytokine Interplay in Non-Subtype B HIV-1 Infections in Nigeria and Malawi.
AIDS Res Hum Retroviruses
2020
32605062
Multi-Laboratory Comparison of Next-Generation to Sanger-Based Sequencing for HIV-1 Drug Resistance Genotyping.
Viruses
2020
32796074
Two Genetic Differences between Closely Related Zika Virus Strains Determine Pathogenic Outcome in Mice.
J Virol
2020
32759675
Fact and Fiction about 1%: Next Generation Sequencing and the Detection of Minor Drug Resistant Variants in HIV-1 Populations with and without Unique Molecular Identifiers.
Viruses
2020
33021198
The HIV-1 latent reservoir is largely sensitive to circulating T cells.
Elife
2020
32269129
Deep Sequencing Reveals Compartmentalized HIV-1 in the Semen of Men with and without Sexually Transmitted Infection-Associated Urethritis.
J Virol
2020
31361460
Picomolar to Micromolar: Elucidating the Role of Distal Mutations in HIV-1 Protease in Conferring Drug Resistance.
ACS Chem Biol
2019
31597754
The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation.
Sci Transl Med
2019
29756455
Characterization of the Transmitted Virus in an Ongoing HIV-1 Epidemic Driven by Injecting Drug Use.
AIDS Res Hum Retroviruses
2018
30081054
Evolutionary pathways to NS5A inhibitor resistance in genotype 1 hepatitis C virus.
Antiviral Res
2018
30010965
Using Primer-ID Deep Sequencing to Detect Recent Human Immunodeficiency Virus Type 1 Infection.
J Infect Dis
2018
27683060
Quantification of the Latent HIV-1 Reservoir Using Ultra Deep Sequencing and Primer ID in a Viral Outgrowth Assay.
J Acquir Immune Defic Syndr
2017
28077653
Characterizing HIV-1 Splicing by Using Next-Generation Sequencing.
J Virol
2017
28859436
Prevalence of Drug-Resistant Minority Variants in Untreated HIV-1-Infected Individuals With and Those Without Transmitted Drug Resistance Detected by Sanger Sequencing.
J Infect Dis
2017
28688086
Sequencing the Biology of Entry: The Retroviral env Gene.
Curr Top Microbiol Immunol
2017
27132284
Diversity and Tropism of HIV-1 Rebound Virus Populations in Plasma Level After Treatment Discontinuation.
J Infect Dis
2016
27382162
Cytosine deamination and the precipitous decline of spontaneous mutation during Earth's history.
Proc Natl Acad Sci U S A
2016
27226378
Deep Sequencing of the HIV-1 env Gene Reveals Discrete X4 Lineages and Linkage Disequilibrium between X4 and R5 Viruses in the V1/V2 and V3 Variable Regions.
J Virol
2016
25748056
Primer ID Informs Next-Generation Sequencing Platforms and Reveals Preexisting Drug Resistance Mutations in the HIV-1 Reverse Transcriptase Coding Domain.
AIDS Res Hum Retroviruses
2015
26041299
Primer ID Validates Template Sampling Depth and Greatly Reduces the Error Rate of Next-Generation Sequencing of HIV-1 Genomic RNA Populations.
J Virol
2015
26223642
R5 Macrophage-Tropic HIV-1 in the Male Genital Tract.
J Virol
2015
24901464
Total daily pill burden in HIV-infected patients in the southern United States.
AIDS Patient Care STDS
2014
22544191
Monitoring HIV drug resistance using early warning indicators in China: results from a pilot survey conducted in 2008.
Clin Infect Dis
2012
21600849
Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study.
Lancet Infect Dis
2011
20032784
Hepatitis B and hepatitis C seroprevalence in children receiving antiretroviral therapy for human immunodeficiency virus-1 infection in China, 2005-2009.
J Acquir Immune Defic Syndr
2010
20500898
Recent key advances in human immunodeficiency virus medicine and implications for China.
AIDS Res Ther
2010
1 - 41 of 41
Column Actions
Search
Recommended Authors
Melissa L Smith
University of Louisville
Career Start Year
2016
Number of shared co-authors
0
Manon Ragonnet-Cronin
Imperial College London
Career Start Year
2010
Number of shared co-authors
0
Tian-Hao Zhang
David Geffen School of Medicine, University of California los angeles
Career Start Year
2009
Number of shared co-authors
0
Alexander L Greninger
University of Washington Medical Center
Career Start Year
2008
Number of shared co-authors
6
Judd F Hultquist
Northwestern University Feinberg School of Medicine
Career Start Year
2008
Number of shared co-authors
2
Joel O Wertheim
University of California
Career Start Year
2007
Number of shared co-authors
2
Will Dampier
Drexel University College of Medicine
Career Start Year
2007
Number of shared co-authors
0
Fabio Zanini
Stanford University
Career Start Year
2006
Number of shared co-authors
0
Roger D Kouyos
Institute of Medical Virology, University of Zurich
Career Start Year
2006
Number of shared co-authors
1
Pavitra Roychoudhury
Fred Hutchinson Cancer Center
Career Start Year
2004
Number of shared co-authors
5
Marek Widera
Goethe University Frankfurt, University Hospital, Institute for Medical Virology
Career Start Year
2004
Number of shared co-authors
2
Timothy J Henrich
University of California san francisco
Career Start Year
2002
Number of shared co-authors
3
Satish K Pillai
Vitalant Research Institute, USA University of California san francisco
Career Start Year
2001
Number of shared co-authors
4
Davey M Smith
University of California San Diego
Career Start Year
2001
Number of shared co-authors
5
Jacques Fellay
Ecole Polytechnique Federale de Lausanne
Career Start Year
2001
Number of shared co-authors
2
Sudhir Penugonda
Northwestern University Feinberg School of Medicine
Career Start Year
2000
Number of shared co-authors
0
Pardis C Sabeti
Harvard University
Career Start Year
1997
Number of shared co-authors
4
Viviana Simon
Icahn School of Medicine at Mount Sinai
Career Start Year
1997
Number of shared co-authors
2
Oliver Laeyendecker
Department of Medicine Johns Hopkins Medicine. Baltimore MD 21205USA.
Career Start Year
1996
Number of shared co-authors
1
Adam S Lauring
University of Michigan ann arbor
Career Start Year
1995
Number of shared co-authors
6
Wei Shao
Inc., Frederick National Laboratory for Cancer Research
Career Start Year
1993
Number of shared co-authors
2
Sharon R Lewin
The University of Melbourne at the Peter Doherty Institute for Infection and Immunity
Career Start Year
1993
Number of shared co-authors
1
Keith R Jerome
Fred Hutchinson Cancer Center
Career Start Year
1991
Number of shared co-authors
5
Rafael Delgado
Instituto de Investigacion Hospital 12 de Octubre (imas12)
Career Start Year
1988
Number of shared co-authors
2
Michael S Saag
University of Alabama at Birmingham
Career Start Year
1980
Number of shared co-authors
5
Bonaventura Clotet
IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol
Career Start Year
1979
Number of shared co-authors
3
Steven M Wolinsky
Northwestern University Feinberg School of Medicine
Career Start Year
1979
Number of shared co-authors
4
Daniel R Kuritzkes
Brigham and Women's Hospital, Harvard Medical School
Career Start Year
1979
Number of shared co-authors
5
Amalio Telenti
Vir Biotechnology Inc.
Career Start Year
1977
Number of shared co-authors
2
Douglas D Richman
Center for AIDS Research, University of California San Diego
Career Start Year
1970
Number of shared co-authors
3
row(s) 1 - 30 of 30
Collaborators
Ronald Swanstrom
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Co-authored papers
33
Joseph J Eron
Co-authored papers
7
Ralph S Baric
University of North Carolina
Co-authored papers
4
Simon D W Frost
Co-authored papers
2
Celia A Schiffer
University of Massachusetts Chan Medical School
Co-authored papers
2
Corbin D Jones
University of North Carolina at Chapel Hill
Co-authored papers
2
Sergei L Kosakovsky Pond
Co-authored papers
2
Nathan D Grubaugh
Yale School of Public Health
Co-authored papers
1
Mark T Heise
University of North Carolina at Chapel Hill.
Co-authored papers
1
Kien Pham
Yale School of Public Health
Co-authored papers
1
Ian Frank
IF School of Medicine, University of Pennsylvania
Co-authored papers
1
Amy C Sims
The University of North Carolina at Chapel Hill
Co-authored papers
1
Nadia R Roan
University of California, USA Gladstone Institutes san francisco
Co-authored papers
1
Umadevi Veluvolu
Co-authored papers
1
Anne M Hahn
Yale School of Public Health
Co-authored papers
1
Sarah R Leist
University of North Carolina at Chapel Hill
Co-authored papers
1
Roger Paredes
Hospital Germans Trias i Pujol
Co-authored papers
1
Jeffrey M Jacobson
Co-authored papers
1
Mark R Denison
Vanderbilt University Medical Center
Co-authored papers
1
Rachel L Graham
University of North Carolina
Co-authored papers
1
David C Montefiori
Co-authored papers
1
David Ferguson
Yale School of Medicine
Co-authored papers
1
Laura J Stevens
Vanderbilt University Medical Center
Co-authored papers
1
Mallery I Breban
Yale School of Public Health
Co-authored papers
1
Wade Schulz (CM4AI)
Yale University
Co-authored papers
1
Steven G Deeks
University of California san francisco
Co-authored papers
1
Chrispin Chaguza
Yale School of Public Health, YaleUniversity
Co-authored papers
1
Scott C Roberts
Yale School of Medicine
Co-authored papers
1
Alexandra Sch??fer
University of North Carolina at Chapel Hill
Co-authored papers
1
Verity Hill
Yale School of Public Health
Co-authored papers
1
1 - 30